Advanced Biomed Inc.

This section discusses the material components of the executive compensation program for our named executive officers for the years ended June 30, 2025 and 2024.

Summary Compensation Table

The following table presents the compensation awarded to or earned by or paid to our named executive officers during the fiscal years ended June 30, 2025 and 2024.

Outstanding Equity Awards at Fiscal Year End

There were no outstanding equity awards as of June 30, 2025.

Share Incentive Plans

Effective March 30, 2023, our Stock Incentive Plan (the “2023 Plan”) was approved by our Board of Directors. Under the 2023 Plan, the Board of Directors may grant options or purchase rights to purchase Common Stock to officers, employees, and other persons who provide services to us or any related company. The participants to whom awards are granted, the type of awards granted, the number of shares covered for each award, and the purchase or exercise price, conditions and other terms of each award are determined by the Board of Directors, except that the term of the options shall not exceed 10 years. A total of 15 million shares of our Common Stock are subject to the 2023 Plan and maybe either a qualified or non-qualified stock option. The shares issued for the 2023 Plan may be either treasury or authorized and unissued shares. As of June 30, 2025, we have granted no stock options to purchase any shares of our Common Stock under the 2023 Plan.

Employment Agreements with Our Named Executive Officers and Potential Payments Upon Termination or Change in Control

Director Compensations

For the fiscal year ended June 30, 2025, we and our subsidiaries paid aggregate cash compensation of approximately $8,000 to our executive and non-executive directors as a group. Our Chief Executive Officer and Chief Technology Officer are executive directors whose compensation were disclosed under “Item 11 - Executive Compensation-Summary Compensation Table.” We do not pay or set aside any amounts for pensions, retirement or other benefits for directors.

The following table shows the compensation paid to our non-employee directors during the year ended June 30, 2025.